GlassScriptPhysician profile
Doanh Nguyen
NPI 1720090921
$1,509.58
in general payments reported to CMS, 2019-2025
17 companies · $41.89 in 2025
The $41.89 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2021: $277 · 2022: $313 · 2023: $508 · 2024: $217 · 2025: $41.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $240.70 | 2021-2022 | |
| Pfizer INC. | $204.73 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $172.59 | 2022-2023 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.55 | 2019-2023 | Relistor |
| Glaxosmithkline, LLC. | $144.68 | 2023-2024 | Arexvy, Nucala |
| Abbvie INC. | $104.87 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Averitas Pharma INC. | $76.45 | 2023-2025 | Qutenza |
| Redhill Biopharma INC. | $70.50 | 2021 | |
| Horizon Therapeutics Plc | $57.82 | 2021-2022 | |
| Optinose US, INC. | $46.84 | 2023 | |
| Daiichi Sankyo INC. | $34.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $22.90 | 2023 | Ztlido |
| Impel Pharmaceuticals INC. | $22.53 | 2022 | |
| Avanos Medical | $22.46 | 2023 | Trivisc Sodium Hyaluronate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $19.74 | 2025 | |
| Forte Bio-Pharma LLC | $17.24 | 2023 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doanh Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.